HDAC9 and malignant peripheral nerve sheath tumor: FT895 is a selective HDAC inhibitor; therefore, the initial focus to uncover the mechanism underlying FT895’s synergistic effect on the cytotoxicity of cordycepin in MPNST cells is to examine the generation of ROS.